Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

$TGTX Good TG week, nice to see the trend continue since approval. 😎🙏😎

They're FDA approved, have the best in class treatment, and is more affordable than the others.

Best drug approval of 2022.

Freshly approved drug and undervalued would mean the JP conference should be ideal for us.

$AUPH regardless of where the market goes 2023 will be a very good year for $AUPH and $TGTX Both having best in class block buster potential drugs approved

$TGTX successfully on time launch in Q1 2023 and EU approval mid year, we will be back to highs.

$TGTX is up 13% continued momentum following MS drug approvals.

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$SAVA I'm loving the move, can't wait for the approval, buy out at $500, sell at $1200.

$SAVA diseases like Alzheimer’s will have more Than 1 drug approved for the indication.. being first is great,

$SAVA FDA approved Biogen's AD drug is bullish for SAVA.

$SAVA biib up 3.00 on approval sava will go up 100+ on approval

no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !

This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.

This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.

Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$CTMX $KALA the next big runner after approval tomorrow wow! !

$KALA FDA approved!

Successful development and potential approval for KPI-012 will be a huge boost for the company.